3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
24
Colorectal Neoplasms
19
Rectal Neoplasms
11
Stomach Neoplasms
9
Colonic Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Carcinoma, Hepatocellular
7
Neoplasm Metastasis
6
Squamous Cell Carcinoma of Head and Neck
5
Neoplasms
5
Liver Neoplasms
5
Esophageal Neoplasms
5
Uterine Cervical Neoplasms
4
Urinary Bladder Neoplasms
4
Osteosarcoma
4
Cholangiocarcinoma
4
Peritoneal Neoplasms
3
Ovarian Neoplasms
3
Neuroblastoma
3
Multiple Myeloma
3
Lung Neoplasms
3
Locally Advanced Rectal Cancer
3
Kidney Neoplasms
3
Inflammatory Breast Neoplasms
3
Turcot syndrome
2
Sarcoma
2
Pancreatic Neoplasms
2
Nasopharyngeal Carcinoma
2
Head and Neck Neoplasms
2
Glioblastoma
2
Interventions
blinatumomab
2
Carboplatin
2
venetoclax
1
treosulfan
1
flumatinib
1
fludarabine phosphate
1
anlotinib
1
aflutinib
1
Whole-Body Irradiation
1
Tyrosine Kinase Inhibitors
1
Peripheral Blood Stem Cell Transplantation
1
Neoadjuvant Therapy
1
Maintenance
1
Interferon alpha-2
1
Inotuzumab Ozogamicin
1
Injections
1
Immunotherapy
1
Drug Therapy
1
Docetaxel
1
Decitabine
1
Cytarabine
1
Cyclophosphamide
1
Chemotherapy, Adjuvant
1
Carmustine
1
Busulfan
1
Bortezomib
1
Blood Specimen Collection
1
Azacitidine
1
Anti-Inflammatory Agents, Non-Steroidal
1
Aminolevulinic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasm, Residual
×
Neoadjuvant Therapy
×
Clear all
NCT00551577
2007-10-31
PRIMOVAR-1
University Hospital, Bonn
Phase 2
Unknown
100 enrolled